Home ›
Companies ›
Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. — Latest News
Every SEC filing by Aclaris Therapeutics, Inc. that we have reported, newest first. Each story links the original filing.
NASDAQ: ACRS · Biotechnology · 3 stories
Share price $3.92
Market cap $622M
Revenue (annual) $8M
Reference market data from a third-party provider, as of the most recent story (16 Nov 2026). Not a valuation or a recommendation.
Aclaris Therapeutics, Inc. share price · last month
Up 3.6% over the last month ($3.48 on 19 Oct → $3.60 on 16 Nov). Daily closing prices. Source: Yahoo Finance .
Show the prices
19 Oct $3.48 20 Oct $3.77 21 Oct $3.81 22 Oct $3.83 23 Oct $3.75 26 Oct $3.79 27 Oct $3.79 28 Oct $3.96 29 Oct $3.99 30 Oct $3.97 2 Nov $3.80 3 Nov $3.74 4 Nov $3.68 5 Nov $3.61 6 Nov $3.90 9 Nov $4.24 10 Nov $4.15 11 Nov $4.34 12 Nov $4.00 13 Nov $3.92 16 Nov $3.60